GlobeNewswire - Industry News on Medical Supplies
http://www.yebxqs.cn/RssFeed/industry/4537-Medical%20Supplies/feedTitle/GlobeNewswire%20-%20Industry%20News%20on%20Medical%20Supplies
Contains the last 20 releasesnewsdesk@globenewswire.com (NewsDesk)Thu, 04 Mar 2021 21:15:00 GMTwebmaster@globenewswire.com (Webmaster)http://www.yebxqs.cn/news-release/2021/03/04/2187612/0/en/Cancer-Genetics-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference.html
http://www.yebxqs.cn/news-release/2021/03/04/2187612/0/en/Cancer-Genetics-to-Present-at-the-H-C-Wainwright-Global-Life-Sciences-Conference.html
Nasdaq:CGIXUS13739U1043Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences ConferenceRUTHERFORD, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts, Chief Executive Officer, will present at H.C. Wainwright’s Global Life Sciences Conference. The event is being held virtually from March 9-10, 2021. ]]>Thu, 04 Mar 2021 21:15 GMT2187612enGlobeNewswire Inc.Cancer Genetics, Inc.Thu, 04 Mar 2021 21:15 GMTPress releasesCancer Genetics Inc.CGIXH.C. Wainwright Global LifeConferencevivoPharmbiotechnology companiespharmaceutical industryhttp://www.yebxqs.cn/news-release/2021/03/04/2187615/0/en/CooperCompanies-Announces-First-Quarter-2021-Results.html
http://www.yebxqs.cn/news-release/2021/03/04/2187615/0/en/CooperCompanies-Announces-First-Quarter-2021-Results.html
NYSE:COOUS2166484020CooperCompanies Announces First Quarter 2021 ResultsSAN RAMON, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal first quarter ended January 31, 2021. ]]>Thu, 04 Mar 2021 21:15 GMT2187615enGlobeNewswire Inc.The Cooper Companies, Inc.Thu, 04 Mar 2021 21:15 GMTCalendar of EventsEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/04/2187604/0/en/Anika-Reports-Fourth-Quarter-and-Year-End-2020-Financial-Results.html
http://www.yebxqs.cn/news-release/2021/03/04/2187604/0/en/Anika-Reports-Fourth-Quarter-and-Year-End-2020-Financial-Results.html
Nasdaq:ANIKUS0352551081Anika Reports Fourth Quarter and Year-End 2020 Financial ResultsCompleted Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year, Full Year 2020 Revenue up 14% Well Positioned for Growth in 2021]]>Thu, 04 Mar 2021 21:05 GMT2187604enGlobeNewswire Inc.Anika Therapeutics Inc.Thu, 04 Mar 2021 21:05 GMTCalendar of EventsEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/04/2187073/0/en/Ortho-Clinical-Diagnostics-to-Report-Fourth-Quarter-and-Full-Year-2020-Results-on-March-18-2021.html
http://www.yebxqs.cn/news-release/2021/03/04/2187073/0/en/Ortho-Clinical-Diagnostics-to-Report-Fourth-Quarter-and-Full-Year-2020-Results-on-March-18-2021.html
Nasdaq:OCDXUS68752DAC20Ortho Clinical Diagnostics to Report Fourth Quarter and Full Year 2020 Results on March 18, 2021RARITAN, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care, today announced it will report results for the fourth quarter and full year 2020 ended January 3, 2021, after the market close on March 18, 2021. ]]>Thu, 04 Mar 2021 13:00 GMT2187073enGlobeNewswire Inc.Ortho-Clinical Diagnostics, IncThu, 04 Mar 2021 13:01 GMTCalendar of Eventshttp://www.yebxqs.cn/news-release/2021/03/04/2186901/0/en/EssilorLuxottica-Full-Year-2020-Results-Conference-Call-Invitation.html
http://www.yebxqs.cn/news-release/2021/03/04/2186901/0/en/EssilorLuxottica-Full-Year-2020-Results-Conference-Call-Invitation.html
Paris:ELFR0000121667EssilorLuxottica : Full Year 2020 Results Conference Call InvitationFull Year 2020 Results Conference Call Invitation]]>Thu, 04 Mar 2021 11:00 GMT2186901enGlobeNewswire Inc.EssilorLuxotticaThu, 04 Mar 2021 11:01 GMTEarnings Releases and Operating ResultsEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/03/2186524/0/fr/Crossject-Information-relative-au-nombre-de-droits-de-vote-et-d-actions-composant-le-capital-social.html
http://www.yebxqs.cn/news-release/2021/03/03/2186524/0/fr/Crossject-Information-relative-au-nombre-de-droits-de-vote-et-d-actions-composant-le-capital-social.html
Paris:ALCJFR0011716265Crossject: Information relative au nombre de droits de vote et d'actions composant le capital socialCommuniqué de Presse]]>Wed, 03 Mar 2021 17:20 GMT2186524frGlobeNewswire Inc.CROSSJECTWed, 03 Mar 2021 17:21 GMTOther NewsEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/02/2185726/0/en/CooperCompanies-to-Participate-in-the-KeyBanc-Life-Sciences-MedTech-Investor-Forum.html
http://www.yebxqs.cn/news-release/2021/03/02/2185726/0/en/CooperCompanies-to-Participate-in-the-KeyBanc-Life-Sciences-MedTech-Investor-Forum.html
NYSE:COOUS2166484020CooperCompanies to Participate in the KeyBanc Life Sciences MedTech Investor ForumSAN RAMON, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:15PM ET.]]>Tue, 02 Mar 2021 21:15 GMT2185726enGlobeNewswire Inc.The Cooper Companies, Inc.Tue, 02 Mar 2021 21:15 GMTCalendar of Eventshttp://www.yebxqs.cn/news-release/2021/03/01/2184716/0/en/CooperCompanies-Acquires-Safe-Obstetric-Systems.html
http://www.yebxqs.cn/news-release/2021/03/01/2184716/0/en/CooperCompanies-Acquires-Safe-Obstetric-Systems.html
NYSE:COOUS2166484020CooperCompanies Acquires Safe Obstetric SystemsSAN RAMON, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that CooperSurgical has acquired Safe Obstetric Systems, a privately held manufacturer of the medical device, Fetal Pillow?. This FDA approved product is used to elevate the fetal head during a fully dilated cesarean section making the delivery easier and less traumatic for the mother and baby. ]]>Mon, 01 Mar 2021 21:15 GMT2184716enGlobeNewswire Inc.The Cooper Companies, Inc.Mon, 01 Mar 2021 21:15 GMTMergers and Acquisitionshttp://www.yebxqs.cn/news-release/2021/03/01/2184719/0/en/OraSure-Technologies-Inc-Announces-2020-Full-Year-and-Fourth-Quarter-Financial-Results-and-Provides-COVID-19-Update.html
http://www.yebxqs.cn/news-release/2021/03/01/2184719/0/en/OraSure-Technologies-Inc-Announces-2020-Full-Year-and-Fourth-Quarter-Financial-Results-and-Provides-COVID-19-Update.html
Nasdaq:OSURUS68554V1089OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 UpdateFull-Year 2020 Net Revenues of $172 Million Increased 11% Year-Over-Year, Driven by $50 Million in Sales of Oral Fluid Collection Devices for COVID-19 Molecular Testing ]]>Mon, 01 Mar 2021 21:15 GMT2184719enGlobeNewswire Inc.OraSure Technologies, Inc.Mon, 01 Mar 2021 21:15 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/01/2184691/0/en/Silk-Road-Medical-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html
http://www.yebxqs.cn/news-release/2021/03/01/2184691/0/en/Silk-Road-Medical-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html
Nasdaq:SILKUS82710M1009Silk Road Medical Reports Fourth Quarter and Full Year 2020 Financial ResultsSubmitted PMA Supplement for ENROUTE Stent in Standard Surgical Risk Patients]]>Mon, 01 Mar 2021 21:05 GMT2184691enGlobeNewswire Inc.Silk Road MedicalMon, 01 Mar 2021 21:06 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/01/2183990/0/en/Coloplast-A-S-Transactions-in-connection-with-share-buy-back-programme-week-8.html
http://www.yebxqs.cn/news-release/2021/03/01/2183990/0/en/Coloplast-A-S-Transactions-in-connection-with-share-buy-back-programme-week-8.html
Copenhagen:COLO BDK0060448595Coloplast A/S - Transactions in connection with share buy-back programme, week 8 As mentioned in Announcement no. 02/2021 Coloplast is initiating a share buyback programme totalling up to DKK 500 million. ]]>Mon, 01 Mar 2021 10:59 GMT2183990enGlobeNewswire Inc.Coloplast A/SMon, 01 Mar 2021 10:59 GMTCompany AnnouncementChanges in company's own sharesEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/03/01/2183990/0/da/Coloplast-A-S-Transaktioner-i-henhold-til-aktietilbagek%C3%B8bsprogram-uge-8.html
http://www.yebxqs.cn/news-release/2021/03/01/2183990/0/da/Coloplast-A-S-Transaktioner-i-henhold-til-aktietilbagek%C3%B8bsprogram-uge-8.html
Copenhagen:COLO BDK0060448595Coloplast A/S - Transaktioner i henhold til aktietilbagek?bsprogram, uge 8Som meddelt i Selskabsmeddelelse nr. 02/2021 har Coloplast iv?rksat et tilbagek?bsprogram p? i alt 500 millioner kroner.]]>Mon, 01 Mar 2021 10:59 GMT2183990daGlobeNewswire Inc.Coloplast A/SMon, 01 Mar 2021 10:59 GMTCompany AnnouncementChanges in company's own sharesEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/02/25/2182922/0/en/ICU-Medical-Inc-Announces-Fourth-Quarter-2020-Results-and-Provides-Fiscal-Year-2021-Guidance.html
http://www.yebxqs.cn/news-release/2021/02/25/2182922/0/en/ICU-Medical-Inc-Announces-Fourth-Quarter-2020-Results-and-Provides-Fiscal-Year-2021-Guidance.html
Nasdaq:ICUIUS44930G1076ICU Medical, Inc. Announces Fourth Quarter 2020 Results and Provides Fiscal Year 2021 GuidanceSAN CLEMENTE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31, 2020. ]]>Thu, 25 Feb 2021 21:05 GMT2182922enGlobeNewswire Inc.ICU Medical, Inc.Thu, 25 Feb 2021 21:05 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/02/25/2182933/0/en/Study-Published-in-JAMA-Finds-Hospital-Availability-of-TCAR-Associated-with-an-Improvement-in-Overall-Outcomes-for-Carotid-Revascularization.html
http://www.yebxqs.cn/news-release/2021/02/25/2182933/0/en/Study-Published-in-JAMA-Finds-Hospital-Availability-of-TCAR-Associated-with-an-Improvement-in-Overall-Outcomes-for-Carotid-Revascularization.html
Nasdaq:SILKUS82710M1009Study Published in JAMA Finds Hospital Availability of TCAR Associated with an Improvement in Overall Outcomes for Carotid RevascularizationSUNNYVALE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc.?(Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced positive results from a comparative-effectiveness study have been published in JAMA Network Open. ]]>Thu, 25 Feb 2021 21:05 GMT2182933enGlobeNewswire Inc.Silk Road MedicalThu, 25 Feb 2021 21:05 GMTHealthhttp://www.yebxqs.cn/news-release/2021/02/25/2182493/0/en/Align-Technology-s-Invisalign-Brand-to-Become-Official-Smile-Partner-of-The-Golden-State-Warriors-Santa-Cruz-Warriors-and-Golden-Guardians.html
http://www.yebxqs.cn/news-release/2021/02/25/2182493/0/en/Align-Technology-s-Invisalign-Brand-to-Become-Official-Smile-Partner-of-The-Golden-State-Warriors-Santa-Cruz-Warriors-and-Golden-Guardians.html
Nasdaq:ALGNUS0162551016Align Technology’s Invisalign Brand to Become Official Smile Partner of The Golden State Warriors, Santa Cruz Warriors, and Golden GuardiansInvisalign brand sponsorship to reach Warriors fans globally through different fan experiences – arena, digital, and esports]]>Thu, 25 Feb 2021 13:30 GMT2182493enGlobeNewswire Inc.Align Technology, Inc.Thu, 25 Feb 2021 13:31 GMT ]]>GlobeNewswire Inc.Press releaseshttp://www.yebxqs.cn/news-release/2021/02/24/2181813/0/en/OraSure-Technologies-to-Present-at-the-Raymond-James-42nd-Annual-Institutional-Investors-Conference.html
http://www.yebxqs.cn/news-release/2021/02/24/2181813/0/en/OraSure-Technologies-to-Present-at-the-Raymond-James-42nd-Annual-Institutional-Investors-Conference.html
Nasdaq:OSURUS68554V1089OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors ConferenceBETHLEHEM, Pa., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.?(NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr.?Stephen S. Tang, President and CEO, will speak to the investment community at the Raymond James 42nd Annual Institutional Investors Conference. The conference will be simultaneously webcast over the Internet. ]]>Wed, 24 Feb 2021 21:01 GMT2181813enGlobeNewswire Inc.OraSure Technologies, Inc.Wed, 24 Feb 2021 21:01 GMTCalendar of Eventshttp://www.yebxqs.cn/news-release/2021/02/24/2181741/0/en/EssilorLuxottica-EssilorLuxottica-Board-of-Directors-proposes-nominees-to-the-new-board.html
http://www.yebxqs.cn/news-release/2021/02/24/2181741/0/en/EssilorLuxottica-EssilorLuxottica-Board-of-Directors-proposes-nominees-to-the-new-board.html
Paris:ELFR0000121667EssilorLuxottica : EssilorLuxottica Board of Directors proposes nominees to the new boardEssilorLuxottica Board of Directors proposes nominees to the new board]]>Wed, 24 Feb 2021 17:45 GMT2181741enGlobeNewswire Inc.EssilorLuxotticaWed, 24 Feb 2021 17:45 GMTCompany AnnouncementEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/02/24/2181741/0/fr/EssilorLuxottica-Le-Conseil-d-administration-d-EssilorLuxottica-propose-des-candidats-pour-la-composition-du-nouveau-Conseil.html
http://www.yebxqs.cn/news-release/2021/02/24/2181741/0/fr/EssilorLuxottica-Le-Conseil-d-administration-d-EssilorLuxottica-propose-des-candidats-pour-la-composition-du-nouveau-Conseil.html
Paris:ELFR0000121667EssilorLuxottica : Le Conseil d’administration d’EssilorLuxottica propose des candidats pour la composition du nouveau Conseil Le Conseil d’administration d’EssilorLuxottica propose des candidats pour la composition du nouveau Conseil ]]>Wed, 24 Feb 2021 17:45 GMT2181741frGlobeNewswire Inc.EssilorLuxotticaWed, 24 Feb 2021 17:45 GMTCompany AnnouncementEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/02/24/2181741/0/it/EssilorLuxottica-Il-Consiglio-di-Amministrazione-di-EssilorLuxottica-presenta-la-proposta-dei-candidati-per-la-composizione-del-nuovo-Consiglio.html
http://www.yebxqs.cn/news-release/2021/02/24/2181741/0/it/EssilorLuxottica-Il-Consiglio-di-Amministrazione-di-EssilorLuxottica-presenta-la-proposta-dei-candidati-per-la-composizione-del-nuovo-Consiglio.html
Paris:ELFR0000121667EssilorLuxottica : Il Consiglio di Amministrazione di EssilorLuxottica presenta la proposta dei candidati per la composizione del nuovo ConsiglioIl Consiglio di Amministrazione di EssilorLuxottica presenta la proposta dei candidati per la composizione del nuovo Consiglio]]>Wed, 24 Feb 2021 17:45 GMT2181741itGlobeNewswire Inc.EssilorLuxotticaWed, 24 Feb 2021 17:45 GMTCompany AnnouncementEuropean Regulatory Newshttp://www.yebxqs.cn/news-release/2021/02/24/2181438/0/en/ICU-Medical-Inc-to-Present-at-the-Raymond-James-42nd-Annual-Institutional-Investors-Conference.html
http://www.yebxqs.cn/news-release/2021/02/24/2181438/0/en/ICU-Medical-Inc-to-Present-at-the-Raymond-James-42nd-Annual-Institutional-Investors-Conference.html
Nasdaq:ICUIUS44930G1076ICU Medical, Inc. to Present at the Raymond James 42nd Annual Institutional Investors ConferenceSAN CLEMENTE, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James 42nd Annual Institutional Investors Conference, held virtually March 1-3, 2021. ]]>Wed, 24 Feb 2021 13:30 GMT2181438enGlobeNewswire Inc.ICU Medical, Inc.Wed, 24 Feb 2021 13:30 GMTCalendar of Events粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号